Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Disease Markers
Volume 2016 (2016), Article ID 1857067, 8 pages
http://dx.doi.org/10.1155/2016/1857067
Research Article

Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma

1Department of Medical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China
2Key Medical Laboratory of Henan Province, Zhengzhou, Henan 450052, China
3Department of Medical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China

Received 24 October 2015; Accepted 20 January 2016

Academic Editor: Xiaohong Li

Copyright © 2016 Shuling Dong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. K. Rustgi and H. B. El-Serag, “Esophageal carcinoma,” The New England Journal of Medicine, vol. 371, no. 26, pp. 2499–2509, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Pennathur, M. K. Gibson, B. A. Jobe, and J. D. Luketich, “Oesophageal carcinoma,” The Lancet, vol. 381, no. 9864, pp. 400–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Mroczko, M. Kozłowski, M. Groblewska et al., “The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients,” Clinica Chimica Acta, vol. 389, no. 1-2, pp. 61–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Song and S. J. Meltzer, “MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers,” Gastroenterology, vol. 143, no. 1, pp. 35–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Turchinovich, L. Weiz, and B. Burwinkel, “Extracellular miRNAs: the mystery of their origin and function,” Trends in Biochemical Sciences, vol. 37, no. 11, pp. 460–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. C. Lee, R. L. Feinbaum, and V. Ambros, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Romero-Cordoba, I. Salido-Guadarrama, M. Rodriguez-Dorantes, and A. Hidalgo-Miranda, “miRNA biogenesis: biological impact in the development of cancer,” Cancer Biology & Therapy, vol. 15, no. 11, pp. 1444–1455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Li and K. V. Kowdley, “MicroRNAs in common human diseases,” Genomics, Proteomics & Bioinformatics, vol. 10, no. 5, pp. 246–253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Lawrie, S. Gal, H. M. Dunlop et al., “Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma,” British Journal of Haematology, vol. 141, no. 5, pp. 672–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Shen, S. A. Stass, and F. Jiang, “MicroRNAs as potential biomarkers in human solid tumors,” Cancer Letters, vol. 329, no. 2, pp. 125–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Lindner, J. Haier, Z. Wang, D. I. Watson, D. J. Hussey, and R. Hummel, “Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers,” Clinical Science, vol. 128, no. 1, pp. 1–15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Takeshita, I. Hoshino, M. Mori et al., “Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma,” British Journal of Cancer, vol. 108, no. 3, pp. 644–652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Komatsu, D. Ichikawa, H. Takeshita et al., “Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma,” British Journal of Cancer, vol. 105, no. 1, pp. 104–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Zhang, Q. Wang, D. Zhao et al., “The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma,” Clinical Science, vol. 121, no. 10, pp. 437–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Zhang, C. Wang, X. Chen et al., “Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma,” Clinical Chemistry, vol. 56, no. 12, pp. 1871–1879, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. T. Wang, M. Xu, C. X. Xu, Z. Song, and H. Jin, “Decreased expression of miR216a contributes to non-small-cell lung cancer progression,” Clinical Cancer Research, vol. 20, no. 17, pp. 4705–4716, 2014. View at Publisher · View at Google Scholar
  18. L. Li and H. Q. Ma, “MicroRNA216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B,” Molecular Medicine Reports, vol. 12, no. 2, pp. 3156–3162, 2015. View at Publisher · View at Google Scholar
  19. P.-J. Chen, S.-H. Yeh, W.-H. Liu et al., “Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis,” Hepatology, vol. 56, no. 2, pp. 632–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Xia, L. L. P. J. Ooi, and K. M. Hui, “MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer,” Hepatology, vol. 58, no. 2, pp. 629–641, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Deng, H. Tang, Y. Zhou et al., “Mir-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma,” Journal of Cell Science, vol. 124, no. 17, pp. 2997–3005, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Y. Liu, S. J. Zhou, Y. L. Deng et al., “MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway,” Cell Death & Disease, vol. 6, no. 3, Article ID e1670, 2015. View at Publisher · View at Google Scholar
  23. X.-Y. Kong, Y.-Q. Du, L. Li et al., “Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis,” World Journal of Gastroenterology, vol. 16, no. 36, pp. 4599–4604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Endo, H. Weng, N. Kito, Y. Fukushima, and N. Iwa, “MiR-216a and miR-216b as markers for acute phased pancreatic injury,” Biomedical Research, vol. 34, no. 4, pp. 179–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Link, V. Becker, A. Goel, T. Wex, and P. Malfertheiner, “Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer,” PLoS ONE, vol. 7, no. 8, Article ID e42933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du, “Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer,” International Journal of Cancer, vol. 127, no. 1, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, “Characterization of extracellular circulating microRNA,” Nucleic Acids Research, vol. 39, no. 16, pp. 7223–7233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Cortez and G. A. Calin, “MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases,” Expert Opinion on Biological Therapy, vol. 9, no. 6, pp. 703–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Y. Kim, Y.-H. Lee, and Y.-S. Bae, “MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting α subunit of protein kinase CKII in human colorectal cancer cells,” Biochemical and Biophysical Research Communications, vol. 429, no. 3-4, pp. 173–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Zhang, H. Shi, S. Lin, M. Ba, and S. Cui, “MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy,” Oncology Reports, vol. 34, no. 3, pp. 1557–1564, 2015. View at Publisher · View at Google Scholar
  33. N. Lynam-Lennon, J. V. Reynolds, L. Marignol, O. M. Sheils, G. P. Pidgeon, and S. G. Maher, “MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma,” Journal of Molecular Medicine, vol. 90, no. 12, pp. 1449–1458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Komatsu, D. Ichikawa, S. Hirajima et al., “Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma,” British Journal of Cancer, vol. 111, no. 8, pp. 1614–1624, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Kurashige, H. Kamohara, M. Watanabe et al., “Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma,” Journal of Surgical Oncology, vol. 106, no. 2, pp. 188–192, 2012. View at Publisher · View at Google Scholar · View at Scopus